位置:首页 > 蛋白库 > HCFC2_HUMAN
HCFC2_HUMAN
ID   HCFC2_HUMAN             Reviewed;         792 AA.
AC   Q9Y5Z7; B2R8Q5; C0H5X3;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   03-AUG-2022, entry version 168.
DE   RecName: Full=Host cell factor 2;
DE            Short=HCF-2;
DE   AltName: Full=C2 factor;
GN   Name=HCFC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=10196288; DOI=10.1128/jvi.73.5.3930-3940.1999;
RA   Johnson K.M., Mahajan S.S., Wilson A.C.;
RT   "Herpes simplex virus transactivator VP16 discriminates between HCF-1 and a
RT   novel family member, HCF-2.";
RL   J. Virol. 73:3930-3940(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION IN A COMPLEX WITH KMT2A.
RX   PubMed=15199122; DOI=10.1128/mcb.24.13.5639-5649.2004;
RA   Yokoyama A., Wang Z., Wysocka J., Sanyal M., Aufiero D.J., Kitabayashi I.,
RA   Herr W., Cleary M.L.;
RT   "Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase
RT   complex with menin to regulate Hox gene expression.";
RL   Mol. Cell. Biol. 24:5639-5649(2004).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-553, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- SUBUNIT: Binds KMT2A/MLL1. Component of the MLL1/MLL complex, at least
CC       composed of KMT2A/MLL1, ASH2L, RBBP5, DPY30, WDR5, MEN1, HCFC1 and
CC       HCFC2 (PubMed:15199122). Interacts with TASOR (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D968, ECO:0000269|PubMed:15199122}.
CC   -!- INTERACTION:
CC       Q9Y5Z7; Q8IVD9: NUDCD3; NbExp=2; IntAct=EBI-592728, EBI-744342;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10196288}. Nucleus
CC       {ECO:0000269|PubMed:10196288}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y5Z7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y5Z7-2; Sequence=VSP_057024, VSP_057025;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Detected at lower
CC       levels in spleen, thymus, prostate, ovary, small intestine and colon.
CC       {ECO:0000269|PubMed:10196288}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF117210; AAD27814.1; -; mRNA.
DR   EMBL; AK313466; BAG36252.1; -; mRNA.
DR   EMBL; AC078819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC089983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97736.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97737.1; -; Genomic_DNA.
DR   EMBL; BC006558; AAH06558.1; -; mRNA.
DR   EMBL; BC033799; AAH33799.1; -; mRNA.
DR   CCDS; CCDS9097.1; -. [Q9Y5Z7-1]
DR   RefSeq; NP_037452.1; NM_013320.2. [Q9Y5Z7-1]
DR   AlphaFoldDB; Q9Y5Z7; -.
DR   SMR; Q9Y5Z7; -.
DR   BioGRID; 118959; 93.
DR   ComplexPortal; CPX-5850; Histone-lysine N-methyltransferase complex, KMT2A variant.
DR   ComplexPortal; CPX-7062; Histone-lysine N-methyltransferase complex, KMT2B variant.
DR   ComplexPortal; CPX-7110; Histone-lysine N-methyltransferase complex, SET1A variant.
DR   ComplexPortal; CPX-7111; Histone-lysine N-methyltransferase complex, SET1B variant.
DR   CORUM; Q9Y5Z7; -.
DR   IntAct; Q9Y5Z7; 45.
DR   MINT; Q9Y5Z7; -.
DR   STRING; 9606.ENSP00000229330; -.
DR   iPTMnet; Q9Y5Z7; -.
DR   PhosphoSitePlus; Q9Y5Z7; -.
DR   BioMuta; HCFC2; -.
DR   DMDM; 62900381; -.
DR   EPD; Q9Y5Z7; -.
DR   jPOST; Q9Y5Z7; -.
DR   MassIVE; Q9Y5Z7; -.
DR   MaxQB; Q9Y5Z7; -.
DR   PaxDb; Q9Y5Z7; -.
DR   PeptideAtlas; Q9Y5Z7; -.
DR   PRIDE; Q9Y5Z7; -.
DR   ProteomicsDB; 7569; -.
DR   ProteomicsDB; 86554; -. [Q9Y5Z7-1]
DR   Antibodypedia; 1771; 170 antibodies from 21 providers.
DR   DNASU; 29915; -.
DR   Ensembl; ENST00000229330.9; ENSP00000229330.4; ENSG00000111727.12. [Q9Y5Z7-1]
DR   Ensembl; ENST00000544223.6; ENSP00000442942.2; ENSG00000111727.12. [Q9Y5Z7-2]
DR   GeneID; 29915; -.
DR   KEGG; hsa:29915; -.
DR   MANE-Select; ENST00000229330.9; ENSP00000229330.4; NM_013320.3; NP_037452.1.
DR   UCSC; uc001tkj.5; human. [Q9Y5Z7-1]
DR   CTD; 29915; -.
DR   DisGeNET; 29915; -.
DR   GeneCards; HCFC2; -.
DR   HGNC; HGNC:24972; HCFC2.
DR   HPA; ENSG00000111727; Low tissue specificity.
DR   MIM; 607926; gene.
DR   neXtProt; NX_Q9Y5Z7; -.
DR   OpenTargets; ENSG00000111727; -.
DR   PharmGKB; PA134868925; -.
DR   VEuPathDB; HostDB:ENSG00000111727; -.
DR   eggNOG; KOG4152; Eukaryota.
DR   GeneTree; ENSGT00940000160733; -.
DR   HOGENOM; CLU_002603_1_0_1; -.
DR   InParanoid; Q9Y5Z7; -.
DR   OMA; GWIPVPE; -.
DR   OrthoDB; 416932at2759; -.
DR   PhylomeDB; Q9Y5Z7; -.
DR   TreeFam; TF314757; -.
DR   PathwayCommons; Q9Y5Z7; -.
DR   SignaLink; Q9Y5Z7; -.
DR   BioGRID-ORCS; 29915; 18 hits in 1084 CRISPR screens.
DR   ChiTaRS; HCFC2; human.
DR   GenomeRNAi; 29915; -.
DR   Pharos; Q9Y5Z7; Tbio.
DR   PRO; PR:Q9Y5Z7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9Y5Z7; protein.
DR   Bgee; ENSG00000111727; Expressed in calcaneal tendon and 178 other tissues.
DR   ExpressionAtlas; Q9Y5Z7; baseline and differential.
DR   Genevisible; Q9Y5Z7; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0035097; C:histone methyltransferase complex; IBA:GO_Central.
DR   GO; GO:0071339; C:MLL1 complex; IPI:ComplexPortal.
DR   GO; GO:0044665; C:MLL1/2 complex; IPI:ComplexPortal.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; IPI:ComplexPortal.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0006338; P:chromatin remodeling; IBA:GO_Central.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IC:ComplexPortal.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0016032; P:viral process; TAS:ProtInc.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.120.10.80; -; 2.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR011043; Gal_Oxase/kelch_b-propeller.
DR   InterPro; IPR043536; HCF1/2.
DR   InterPro; IPR037932; HCF2.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR015915; Kelch-typ_b-propeller.
DR   PANTHER; PTHR46003; PTHR46003; 1.
DR   PANTHER; PTHR46003:SF2; PTHR46003:SF2; 1.
DR   SMART; SM00060; FN3; 2.
DR   SUPFAM; SSF117281; SSF117281; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF50965; SSF50965; 1.
DR   PROSITE; PS50853; FN3; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Isopeptide bond; Kelch repeat; Nucleus;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN           1..792
FT                   /note="Host cell factor 2"
FT                   /id="PRO_0000119072"
FT   REPEAT          34..79
FT                   /note="Kelch 1"
FT   REPEAT          83..130
FT                   /note="Kelch 2"
FT   REPEAT          207..255
FT                   /note="Kelch 3"
FT   REPEAT          257..303
FT                   /note="Kelch 4"
FT   DOMAIN          359..449
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          583..675
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          677..787
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          399..447
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        415..443
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        553
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         411..412
FT                   /note="GV -> DQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_057024"
FT   VAR_SEQ         413..792
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_057025"
FT   VARIANT         46
FT                   /note="A -> S (in dbSNP:rs2700500)"
FT                   /id="VAR_050044"
FT   VARIANT         268
FT                   /note="G -> A (in dbSNP:rs17035206)"
FT                   /id="VAR_033984"
SQ   SEQUENCE   792 AA;  86779 MW;  EADF5FF25F70856C CRC64;
     MAAPSLLNWR RVSSFTGPVP RARHGHRAVA IRELMIIFGG GNEGIADELH VYNTATNQWF
     LPAVRGDIPP GCAAHGFVCD GTRILVFGGM VEYGRYSNEL YELQASRWLW KKVKPHPPPS
     GLPPCPRLGH SFSLYGNKCY LFGGLANESE DSNNNVPRYL NDFYELELQH GSGVVGWSIP
     VTKGVVPSPR ESHTAVIYCK KDSGSPKMYV FGGMCGARLD DLWQLDLETM SWSKPETKGT
     VPLPRSLHTA SVIGNKMYIF GGWVPHKGEN TETSPHDCEW RCTSSFSYLN LDTTEWTTLV
     SDSQEDKKNS RPRPRAGHCA VAIGTRLYFW SGRDGYKKAL NSQVCCKDLW YLDTEKPPAP
     SQVQLIKATT NSFHVKWDEV STVEGYLLQL STDLPYQAAS SDSSAAPNMQ GVRMDPHRQG
     SNNIVPNSIN DTINSTKTEQ PATKETSMKN KPDFKALTDS NAILYPSLAS NASNHNSHVV
     DMLRKNEGPH TSANVGVLSS CLDVRTVIPE TSVSSTVSST QTMVTQQTIK TESSSTNGAV
     VKDETSLTTF STKSEVDETY ALPATKISRV ETHATATPFS KETPSNPVAT VKAGERQWCD
     VGIFKNNTAL VSQFYLLPKG KQSISKVGNA DVPDYSLLKK QDLVPGTGYR FRVAAINGCG
     IGPFSKISEF KTCIPGFPGA PSAVRISKNV EGIHLSWEPP TSPSGNILEY SAYLAIRTAQ
     IQDNPSQLVF MRIYCGLKTS CIVTAGQLAN AHIDYTSRPA IVFRISAKNE KGYGPATQVR
     WLQGNNKKAP LN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024